These results highlight semaglutides early action on decreasing major cardiovascular events, with significant benefits already evident by the first six months, and for some, even earlier, even before any major weight loss and before most patients would have been titrated to their full target dose of 2.4 mg, lead author Jorge Plutzky, MD, director of preventive cardiology with Brigham and Womens Hospital, said in a statement
For those who are interested, Ill also describe an extreme dietary approach that can generate up to 28 lbs of true fat loss in only 12 weeks (results that outperform GLP-1 only weight loss alone) before looking at the practicalities of using the GLP-1s themselves
Semaglutide, an FDA-approved GLP-1 receptor agonist, addresses those underlying mechanisms directly
Don't take anyone's word on something as life-and-death important as what to eat and feed your family